Basal cell carcinoma of the eyelid and periocular skin

Surv Ophthalmol. 1993 Sep-Oct;38(2):169-92. doi: 10.1016/0039-6257(93)90100-l.


Basal cell carcinoma is the most common human malignancy. This locally invasive tumor rarely metastasizes, but can cause considerable morbidity when on the eyelids and periocular skin. The successful management of BCC requires an awareness of its broad clinical spectrum and knowledge of the risk factors associated with therapeutic failure. The optimal therapy for basal cell carcinoma is controversial. Treatment strategy is formulated on an individual basis, taking into account tumor size, anatomic location, and growth pattern. The immune status and life expectancy of the patient also must be considered. While complete eradication of the tumor is desirable, this can be challenging since basal cell carcinomas often extend beyond their apparent clinical margins. Since prevention is preferable to treatment, the public needs to be informed that the incidence of periocular skin cancers can be reduced with the longterm use of sunscreens, sunglasses, and hats with brims.

Publication types

  • Review

MeSH terms

  • Carcinoma, Basal Cell* / epidemiology
  • Carcinoma, Basal Cell* / pathology
  • Carcinoma, Basal Cell* / therapy
  • Eyelid Neoplasms* / epidemiology
  • Eyelid Neoplasms* / pathology
  • Eyelid Neoplasms* / therapy
  • Facial Neoplasms* / epidemiology
  • Facial Neoplasms* / pathology
  • Facial Neoplasms* / therapy
  • Humans
  • Risk Factors
  • United States / epidemiology